Need perfusion meeting CEUs? Welcome to’s premier online perfusion webinar site for CEUs. has your solution for getting all of your perfusion CEUs in one location all from the comfort of your home. With COVID-19 in 2020 and on-location perfusion meetings and conferences being cancelled, this is the perfect solution for meeting your CEU requirements. The topics are fresh and informative given by a wide array of cardiovascular surgery and cardiovascular perfusion experts. Don’t wait! Get your perfusion CEUs now.

Loading Events

« All Events

Virtual Event Virtual Event
  • This event has passed.

PerfWeb #61 ECMO platform overview: Cost, safety, transportability. Acute Hypoxemic Respiratory Failure. Atrial Septal Defects

June 2, 2021 @ 6:45 am - 10:00 am CDT

Virtual Event Virtual Event
Perfusion Meeting 2021 Card

PerfWeb 61 — Vanderbilt University Medical Center; Department of CV Surgery: Faculty Forum – Tammy Sparacino Journal Club – John Ingram Knowledge Nuggets

Vanderbilt University - VUMC Perfusion Conference Block Card - Perfusion Conference 2021

Vanderbilt University Medical Center; Department of CV Surgery: Faculty Forum – ECMO platform overview: Cost, safety, transportability

J. Hoffman, MD,
Matt Warhoover, CCP,
A. Lepore, CCP
Tammy Sparacino Journal Club Card - Perfusion Conference 2021


Tammy Sparacino Journal Club – Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure

Patients with acute hypoxemic respiratory failure in the intensive care unit (ICU) are treated with supplemental oxygen, but the benefits and harms of different oxygenation targets are unclear. We hypothesized that using a lower target for partial pressure of arterial oxygen (Pao2) would result in lower mortality than using a higher target.
In this multicenter trial, we randomly assigned 2928 adult patients who had recently been admitted to the ICU (≤12 hours before randomization) and who were receiving at least 10 liters of oxygen per minute in an open system or had a fraction of inspired oxygen of at least 0.50 in a closed system to receive oxygen therapy targeting a Pao2 of either 60 mm Hg (lower-oxygenation group) or 90 mm Hg (higher-oxygenation group) for a maximum of 90 days. The primary outcome was death within 90 days.
At 90 days, 618 of 1441 patients (42.9%) in the lower-oxygenation group and 613 of 1447 patients (42.4%) in the higher-oxygenation group had died (adjusted risk ratio, 1.02; 95% confidence interval, 0.94 to 1.11; P=0.64). At 90 days, there was no significant between-group difference in the percentage of days that patients were alive without life support or in the percentage of days they were alive after hospital discharge. The percentages of patients who had new episodes of shock, myocardial ischemia, ischemic stroke, or intestinal ischemia were similar in the two groups (P=0.24).
Tammy Sparacino, CCP
John Ingram, CCP
Joe Basha, CCP
John Ingram Knowledge Nuggets Card - Perfusion Meeting 2021


John Ingram Knowledge Nuggets – Atrial Septal Defects

John Ingram, CCP
Tammy Sparacino, CCP
Joe Basha, CCP

This perfusion meeting is approved for 3.4 Category 1 CEU by American Board of Cardiovascular Perfusion (ABCP)

Register and watch for free @
Get our Perfusion App –
IV Dosage and Rate Calculator –
See Our Schedule:


MediWeb Studio – Perfusion Meeting 2021
123 Ruel Ln
Magnolia, TX 77355 United States
+ Google Map
+1 281 - 667 - 9284
View Venue Website

Submit a Comment

Your email address will not be published. Required fields are marked *